UROGEN PHARMA LTD (URGN) Stock Earnings & Estimates
NASDAQ:URGN - IL0011407140 - Common Stock
19.24 USD
-0.3 (-1.54%)
18.92 USD
-0.32 (-1.66%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 64.36M 33.97% | 82.713M 28.52% | 90.398M 9.29% | 122.58M 35.60% | 281.37M 129.54% | 442.66M 57.32% | 523.51M 18.26% | 749.55M 43.18% | 978.26M 30.51% | 1.512B 54.56% | 1.659B 9.72% | |
| EBITDA YoY % growth | -78.12M 14.59% | -63.831M 18.29% | -95.596M -49.76% | -126.932M -32.78% | -60.25M 52.53% | 18.82M 131.24% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -79.04M 14.36% | -65.536M 17.09% | -96.782M -47.68% | -114.133M -17.93% | 2.702M 102.37% | 118.72M 4,293.78% | 259.25M 118.37% | 449.32M 73.32% | 651.05M 44.90% | 1.201B 84.47% | 1.316B 9.58% | |
| Operating Margin | -122.81% | -79.23% | -107.06% | -93.11% | 0.96% | 26.82% | 49.52% | 59.95% | 66.55% | 79.43% | 79.32% | |
| EPS YoY % growth | -4.78 3.57% | -3.73 22.02% | -3.23 13.40% | -2.88 10.72% | -0.77 73.42% | 1.06 237.87% | 2.60 146.38% | 4.66 79.04% | 6.37 36.65% | 9.57 50.28% | 9.79 2.24% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.68 -23.94% | -0.49 38.80% | -0.69 24.61% | -0.47 55.12% | -0.21 69.70% | -0.04 92.71% |
| Revenue Q2Q % growth | 33.321M 32.21% | 43.886M 78.65% | 45.622M 125.25% | 58.825M 142.93% | 72.24M 116.80% | 83.091M 89.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -23.758M -35.41% | -13.977M 49.46% | -16.685M 54.80% | -13.041M 68.54% | -4.965M 79.10% | -3.371M 75.88% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.05 -15.38% | -0.85 | -0.20 | -23.47% |
| Q1 2025 Q2Q % growth | -0.92 5.15% | -0.82 | -0.10 | -12.75% |
| Q4 2024 Q2Q % growth | -0.80 -11.11% | -0.73 | -0.07 | -8.93% |
| Q3 2024 Q2Q % growth | -0.55 19.12% | -0.83 | 0.28 | 34.01% |
| Q2 2024 Q2Q % growth | -0.91 11.65% | -0.85 | -0.06 | -7.23% |
| Q1 2024 Q2Q % growth | -0.97 25.38% | -0.88 | -0.09 | -9.81% |
| Q4 2023 Q2Q % growth | -0.72 40.98% | -0.69 | -0.03 | -3.81% |
| Q3 2023 Q2Q % growth | -0.68 39.98% | -0.86 | 0.18 | 21.20% |
| Q2 2023 Q2Q % growth | -1.03 12.71% | -1.16 | 0.13 | 11.11% |
| Q1 2023 Q2Q % growth | -1.30 -4.00% | -1.36 | 0.06 | 4.17% |
| Q4 2022 Q2Q % growth | -1.22 3.94% | -1.09 | -0.13 | -11.44% |
| Q3 2022 Q2Q % growth | -1.13 16.07% | -1.18 | 0.05 | 3.97% |
| Q2 2022 Q2Q % growth | -1.18 -0.85% | -1.30 | 0.12 | 9.27% |
| Q1 2022 Q2Q % growth | -1.25 -6.84% | -1.36 | 0.11 | 8.09% |
| Q4 2021 Q2Q % growth | -1.27 7.97% | -1.20 | -0.07 | -5.97% |
| Q3 2021 Q2Q % growth | -1.35 -3.05% | -1.32 | -0.03 | -2.47% |
| Q2 2021 Q2Q % growth | -1.17 18.75% | -1.15 | -0.02 | -1.87% |
| Q1 2021 Q2Q % growth | -1.17 34.64% | -1.32 | 0.15 | 11.42% |
| Q4 2020 Q2Q % growth | -1.38 25.81% | -1.40 | 0.02 | 1.34% |
| Q3 2020 Q2Q % growth | -1.31 -23.58% | -1.52 | 0.21 | 14.09% |
| Q2 2020 Q2Q % growth | -1.44 -33.33% | -1.61 | 0.17 | 10.77% |
| Q1 2020 Q2Q % growth | -1.79 -61.26% | -1.65 | -0.14 | -8.62% |
| Q4 2019 Q2Q % growth | -1.86 | -1.73 | -0.13 | -7.34% |
| Q3 2019 Q2Q % growth | -1.06 | -1.31 | 0.25 | 19.28% |
| Q2 2019 Q2Q % growth | -1.08 | -1.24 | 0.16 | 13.13% |
| Q1 2019 Q2Q % growth | -1.11 | -1.16 | 0.05 | 4.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 24.215M 10.83% | 23.598M | 617K | 2.61% |
| Q1 2025 Q2Q % growth | 20.254M 7.84% | 23.26M | -3.006M | -12.92% |
| Q4 2024 Q2Q % growth | 24.565M 4.40% | 26.147M | -1.582M | -6.05% |
| Q3 2024 Q2Q % growth | 25.204M 20.87% | 24.688M | 516K | 2.09% |
| Q2 2024 Q2Q % growth | 21.848M 3.35% | 24.442M | -2.594M | -10.61% |
| Q1 2024 Q2Q % growth | 18.781M 9.24% | 21.809M | -3.028M | -13.88% |
| Q4 2023 Q2Q % growth | 23.53M 30.07% | 23.02M | 510K | 2.22% |
| Q3 2023 Q2Q % growth | 20.852M 29.52% | 20.43M | 422K | 2.07% |
| Q2 2023 Q2Q % growth | 21.139M 27.34% | 20.523M | 616K | 3.00% |
| Q1 2023 Q2Q % growth | 17.192M 26.78% | 17.525M | -333K | -1.90% |
| Q4 2022 Q2Q % growth | 18.09M 11.87% | 18.882M | -792K | -4.19% |
| Q3 2022 Q2Q % growth | 16.1M 41.85% | 20.549M | -4.449M | -21.65% |
| Q2 2022 Q2Q % growth | 16.6M 27.40% | 17.576M | -976K | -5.55% |
| Q1 2022 Q2Q % growth | 13.56M 81.04% | 15.482M | -1.922M | -12.41% |
| Q4 2021 Q2Q % growth | 16.17M 102.89% | 16.822M | -652K | -3.88% |
| Q3 2021 Q2Q % growth | 11.35M 228.03% | 15.728M | -4.378M | -27.84% |
| Q2 2021 Q2Q % growth | 13.03M 3,421.62% | 11.955M | 1.075M | 8.99% |
| Q1 2021 Q2Q % growth | 7.49M | 9.234M | -1.744M | -18.89% |
| Q4 2020 Q2Q % growth | 7.97M | 7.72M | 250K | 3.24% |
| Q3 2020 Q2Q % growth | 3.46M | 3.405M | 55K | 1.62% |
| Q2 2020 Q2Q % growth | 370K 1,750.00% | 264.517K | 105.483K | 39.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.82% | 1.72% | 2.97% | 4.21% |
| Revenue | -3.04% | -7.46% | -3.01% | 0.4% |